Regulation Mechanisms in the Spanish Pharmaceutical Industry: An Evaluation of the Government-Pharmaceutical Industry Stability Pact 2001-2004

Simple item page
dc.contributor.authorEnzo Piña Mavarez
dc.contributor.authorMaría Eugenia Suárez-Serrano
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T16:25:14Z
dc.date.available2026-03-22T16:25:14Z
dc.date.issued2014
dc.descriptionCitaciones: 1
dc.description.abstractThe purpose of this work is to analyse two things: firstly, the basis of the Government-Pharmaceutical Industry Stability Pact 2001-2004, which aimed to limit annual growth in public pharmaceutical expenditure, creating a favourable environment for research; secondly, assessing whether the proposed objective of creating stability for the Spanish pharmaceutical industry was achieved. It carries out a thorough statistical analysis of a sample of 45 pharmaceutical laboratories, complemented with a cluster analysis of the main variable strategic principles of the industry, revealing that company behaviour has indeed remained stable during the period in question.
dc.identifier.doi10.3232/gcg.2009.v3.n1.05
dc.identifier.urihttps://doi.org/10.3232/gcg.2009.v3.n1.05
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/58133
dc.language.isoen
dc.relation.ispartofJournal of Globalization Competitiveness and Governability
dc.sourceUniversidad de Los Andes
dc.subjectPharmaceutical industry
dc.subjectGovernment (linguistics)
dc.subjectPact
dc.subjectDrug industry
dc.subjectBusiness
dc.subjectWork (physics)
dc.subjectCluster (spacecraft)
dc.subjectSample (material)
dc.subjectStatistical analysis
dc.subjectIndustrial organization
dc.titleRegulation Mechanisms in the Spanish Pharmaceutical Industry: An Evaluation of the Government-Pharmaceutical Industry Stability Pact 2001-2004
dc.typearticle

Files

Collections

Artículo Científico Publicado